Christopher McNair, Phd

I am the Chief Research Informatics Officer for Sidney Kimmel Medical College, Enterprise Associate Director for Data Science at the Sidney Kimmel Comprehensive Cancer Center, and Associate Professor in the Department of Medical Oncology at Thomas Jefferson University. My research focuses on the intersection of cancer informatics, data science, precision medicine, and translational oncology, with an emphasis on leveraging genomic, clinical, and population-level data to advance cancer research and improve patient outcomes. Over the course of my career, I have developed expertise spanning cancer genomics, computational biology, biomedical informatics, clinical research infrastructure, and the integration of real-world clinical data to support translational discovery.

My work has centered on the development and application of data-driven approaches to address challenges in oncology research and precision medicine. Through collaborations with investigators, clinicians, and industry partners, I have led initiatives that integrate molecular, clinical, and operational data to support biomarker discovery, clinical trial innovation, and evidence generation. These efforts have provided me with extensive experience in the design and implementation of scalable research informatics platforms, data science methodologies, and multidisciplinary research programs.

In my leadership roles, I oversee the strategic development of enterprise research informatics and data science capabilities that support clinical, translational, and population health research. This work has provided a broad perspective on the opportunities and challenges associated with leveraging large-scale biomedical data to accelerate scientific discovery and improve healthcare delivery. My experience uniquely positions me to contribute to studies that require expertise in precision oncology, clinical data integration, translational research, and the application of advanced analytics to complex biomedical problems. I am committed to fostering collaborative, team-based science and to developing innovative approaches that bridge research and clinical practice. Through these efforts, I seek to advance the responsible use of data and technology in ways that improve research efficiency, expand access to precision medicine, and ultimately enhance outcomes for patients with cancer.